STOCK TITAN

Forte Biosciences: OrbiMed entities report 0% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Forte Biosciences, Inc. (FBRX) is the issuer in a Schedule 13G/A reporting that OrbiMed Advisors LLC, OrbiMed Capital GP IX LLC, and OrbiMed Capital LLC each beneficially owned 0 shares of its common stock, or 0.0% of the class. The entities exercise investment and voting power through a management committee comprising Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu; each committee member disclaims beneficial ownership of the shares reported.

Beneficially owned shares 0 shares Each of OrbiMed Advisors LLC, OrbiMed Capital GP IX LLC, and OrbiMed Capital LLC
Percent of class 0.0% Each of OrbiMed Advisors LLC, OrbiMed Capital GP IX LLC, and OrbiMed Capital LLC
beneficial ownership regulatory
"Amount beneficially owned: 0"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many FBRX shares do the OrbiMed reporting entities beneficially own?

Each of OrbiMed Advisors LLC, OrbiMed Capital GP IX LLC, and OrbiMed Capital LLC reports 0 shares, or 0.0% of Forte Biosciences’ common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





34962G208

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



ORBIMED ADVISORS LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon/Member
Date:11/16/2026
OrbiMed Capital GP IX LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon/Member
Date:11/16/2026
ORBIMED CAPITAL LLC
Signature:/s/ Carl L. Gordon
Name/Title:Carl L. Gordon/Member
Date:11/16/2026

Keep reading